Heron Therapeutics | HRTX - Zysk Brutto





Zysk Brutto Zmiana Data
ALKERMES USD 60.38M 40.36M 2025-12
Alnylam Pharmaceuticals USD 221.65M 60.52M 2026-03
Amarin USD -852K 7.26M 2025-12
ANI Pharmaceuticals USD 49.52M 39M 2025-09
Anika Therapeutics USD 764K 3M 2025-12
Arrowhead Research USD 28.27M 7.85M 2025-12
Eisai JPY 22B 7.47B 2025-12
Esperion Therapeutics USD 63.67M 95M 2025-12
GlaxoSmithKline GBP 2.14B 919M 2026-03
Heron Therapeutics USD -2.95M 14.54M 2025-12
Insmed USD -326.93M 41.77M 2025-12
Ligand Pharmaceuticals USD 141.14M 102M 2025-09
Merck USD 3.42B 3.32B 2025-12
Nektar Therapeutics USD -34.7M 2.35M 2025-12
Neurocrine Biosciences USD 246.8M 7.4M 2026-03
Omeros USD -65.12M 21.27M 2024-06
Pacira USD 571K 8.95M 2025-12
Regeneron Pharmaceuticals USD 1.04B 719.6M 2025-12
Roche Holding CHF 4.79B 3.01B 2025-06
Sangamo BioSciences USD -36.05M 12.94M 2024-06
Surmodics USD -5.9M 1.61M 2025-06
Ultragenyx Pharmaceutical USD -184M 56M 2026-03
Veracyte USD 40.63M 21.74M 2025-12
Vertex Pharmaceuticals USD 1.33B 32.2M 2025-12